Cargando…
Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
Macular edema (ME) is a common cause of visual loss among eyes with uveitis, and its management can be challenging. Steroids are an effective treatment for ME, and intravitreal dexamethasone (DEX) implants provide sustained steroid release. The purpose of this study is to evaluate intravitreal DEX i...
Autores principales: | Kang, Eugene Yu-Chuan, Garg, Sunir J., Chen, Hsi-Fu, Wu, Wei-Chi, Chen, Linda Yi-Hsing, Chou, Hung-Da, Liu, Laura, Chen, Kuan-Jen, Hwang, Yih-Shiou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432099/ https://www.ncbi.nlm.nih.gov/pubmed/34501209 http://dx.doi.org/10.3390/jcm10173762 |
Ejemplares similares
-
Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter, Rebecca S, et al.
Publicado: (2011) -
Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
por: Lautredou, Cassandra C., et al.
Publicado: (2018) -
Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010) -
Intravitreal therapeutic agents in noninfectious uveitic macular edema
por: Shah, Kunal Kaushik, et al.
Publicado: (2018) -
Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder, Steven J, et al.
Publicado: (2015)